VistaGen Therapeutics (VTGN) Operating Margin (2010 - 2026)
VistaGen Therapeutics (VTGN) operating margin from Jun 30, 2010 to Mar 31, 2026. The current VistaGen Therapeutics (VTGN) operating margin is -3634.78%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of VistaGen Therapeutics (VTGN)
| Year | Operating Margin | Change |
|---|---|---|
| 2026 | -5679.53% | -50.28% |
| 2025 | -11422.45% | +266.68% |
| 2024 | -3115.09% | -112.09% |
| 2023 | 25769.57% | N/A |
| 2022 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2022 | 0.00% | -100.00% |
| 2022 | -4304.50% | +47.02% |
| 2021 | -2927.78% | -17.66% |
| 2021 | -3555.56% | +60.57% |
| 2021 | -2214.29% | +34.61% |
| 2021 | -1644.95% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2017 | -820.00% | +288.26% |
| 2016 | -211.20% | -93.78% |
| 2013 | -3395.00% | +294.77% |
| 2012 | -860.00% | +27.48% |
| 2012 | -674.63% | +19.93% |
| 2011 | -562.50% | +96.88% |
| 2011 | -285.71% | -9.84% |
| 2011 | -316.91% | N/A |
Comparison VistaGen Therapeutics (VTGN) operating margin with competitors
VistaGen Therapeutics (VTGN) operating margin is -3634.78%.